The PD-L1/PD-1 signaling pathway is a tumor hallmark, with the TME inducing the expression of PD-L1 on tumor cells, and blocking the PD-1 receptor can deactivate CAR-T cells. The gene discussed is PDCD1; the disease is neoplasm.